2BB score and signals
Eledon Pharmaceuticals, Inc.’s current 2BB score is 26 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 18 | Very Low |
| Momentum | 58 | Stable |
| Financial strength | 20 | Very Weak |
| Quality | 52 | Normal |
| Risk | 54 | Moderate |
Company facts
| Headquarters | Irvine, California, United States |
| Founded | 2004 |
| Employees | 33 |
| 52-week range | $1.36 – $4.60 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-17 | — | -0.1693 | — | $0.00 |
| 2026-11-12 | — | -0.1938 | — | $0.00 |
| 2026-08-06 | — | -0.1612 | — | $0.00 |
| 2026-05-13 | -0.33 | -0.1862 | $0.00 | $0.00 |
Related companies